Franklin Genomic Advancements ETF
Ticker
HELX
ISIN
US35473P520
Price
USD 34.52
Change Today
+0.28 / 0.803 %
Price 1 year ago
37.61 / -8.2 %
Morningstar
-
52 Week Low
34.25
52 Week High
37.54
200 Day Moving Average 35.45
35.45
50-day Moving Average
35.45
Price evolution
Yearly returns
Peers comparison
Risk factors
1 year
| Parameter | Value |
|---|
1 year
| Parameter | Value |
|---|
History
| Parameter | Value |
|---|---|
| Average Annual Return | -8.619% |
| Average Annual Volatility | 6.234% |
| Sharpe Ratio | -1.38 |
| Sortino Ratio | -0.65 |
| Maximum Drawdown | -9.0% |
| Maximum Drawdown Date | 2026-02-23 |
| Calmar Ratio | 12.15 |
Company information
Summary
The investment seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
Market
US
Category
Health
Expense Ratio
0.50%
Fund family
Franklin Templeton Investments
Morningstar
-
Yield
0.0031
Exchange
BTS
| Sector | Weight |
|---|---|
| Healthcare | 87.34% |
| Basic materials | 6.64% |
| Realestate | 1.82% |
| Technology | 1.16% |
| Consumer cyclical | 0.00% |
| Communication services | 0.00% |
| Consumer defensive | 0.00% |
| Financial services | 0.00% |
| Utilities | 0.00% |
| Industrials | 0.00% |
| Energy | 0.00% |
| Country | Ratio |
|---|---|
| United States | 82.14 |
| Germany | 7.61 |
| Switzerland | 3.46 |
| South Korea | 3.31 |
| United Kingdom | 2.88 |
| Denmark | 0.49 |
| Sweden | 0.12 |
| Argentina | 0.00 |
| Australia | 0.00 |
| Austria | 0.00 |
Holdings
| Symbol | Name | Allocation |
|---|---|---|
| RGEN | Repligen Corp | 6.11% |
| NTLA | Intellia Therapeutics Inc | 6.08% |
| TMO | Thermo Fisher Scientific Inc | 5.71% |
| BRKR | Bruker Corp | 3.84% |
| DHR | Danaher Corp | 3.78% |
| CTLT | Catalent Inc | 3.58% |
| NTRA | Natera Inc | 3.52% |
| BIO | Bio-Rad Laboratories Inc Class A | 3.45% |
| AVTR | Avantor Inc | 3.42% |
| A | Agilent Technologies Inc | 3.4% |
Alternative funds
| Ticker | Name | Isin | Exchange | Expenses | Morningstar | Alpha | Beta |
|---|---|---|---|---|---|---|---|
| FSHCX | Fidelity Select Health Care Services Portfolio | LU005872090 | NAS | 0.73% | 5 | ||
| IHF | iShares U.S. Healthcare Providers ETF | PCX | 0.39% | 5 | +4.12 | ||
| IHI | iShares U.S. Medical Devices ETF | US4642888105 | PCX | 0.39% | 5 | -2.28 | |
| IYH | iShares U.S. Healthcare ETF | US464287762 | PCX | 0.39% | 5 | +5.24 | |
| JFNIX | Janus Henderson Global Life Sciences Fund - I Shares | IE000214191 | NAS | 5 | |||
| JFNNX | Janus Henderson Global Life Sciences Fund Class N Shares | IE000214191 | NAS | 0.67% | 5 | ||
| JNGLX | Janus Henderson Global Life Sciences Fund - D Shares | IE000214191 | NAS | 5 | |||
| SHSKX | BlackRock Health Sciences Opportunities Portfolio Class K | NAS | 5 | ||||
| SHSSX | BlackRock Health Sciences Opportunities Portfolio Institutional Shares | US09247X101 | NAS | 0.84% | 5 | ||
| VHT | Vanguard Health Care Index Fund | US92204A504 | PCX | 0.10% | 5 | +4.91 | |
| XLV | Health Care Select Sector SPDR Fund | IE00BWBXM61 | PCX | 0.10% | 5 | +6.04 |
Sustainability scores
Events
Indicators
Glossary
- Momentum
- A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend. - Inertia
- In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend. - Relative Strength Index (RSI)
- A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction. - Fibonacci's Weighted Moving Average
- A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend. - Williams %R
- A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce. - Relative Volatility Index (RVI)
- A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk. - Commodity Channel Index (CCI)
- A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.